Resultats globals: 8 registres trobats en 0.01 segons.
Articles, 8 registres trobats
Articles 8 registres trobats  
1.
11 p, 703.9 KB Risk of Trypanosoma cruzi infection among travellers visiting friends and relatives to continental Latin America / Sánchez-Montalvá, Adrián (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Salinas, Catalina (Universitat Autònoma de Barcelona) ; Sullerio, Elena (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Salvador, Fernando (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Bosch-Nicolau, Pau (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Crespillo-Andújar, Clara (Hospital Universitario Ramón y Cajal (Madrid)) ; Trigo, Elena (Hospital Universitario La Paz (Madrid)) ; Roure, Silvia (Universitat Autònoma de Barcelona) ; Valerio, Lluís (Universitat Autònoma de Barcelona) ; Espinosa-Pereiro, Juan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Molina Romero, Israel (Hospital Universitari Vall d'Hebron. Institut de Recerca)
Chagas disease (CD) is regarded as a possible risk for travellers to endemic areas of continental Latin America (LA). The aim of the study is to determine the risk of Trypanosoma cruzi (TC) infection among travellers to CD endemic areas and to identify risk factors for acquiring TC infection. [...]
2021 - 10.1371/journal.pntd.0009528
PLoS neglected tropical diseases, Vol. 15 (july 2021)  
2.
9 p, 698.7 KB Association Between Trypanosoma cruzi DNA in Peripheral Blood and Chronic Chagasic Cardiomyopathy : A Systematic Review / Bosch-Nicolau, Pau (Universitat Autònoma de Barcelona. Departament de Medicina) ; Espinosa-Pereiro, Juan (Hospital Universitari Vall d'Hebron) ; Salvador, Fernando (Hospital Universitari Vall d'Hebron) ; Sánchez-Montalvá, Adrián (Universitat Autònoma de Barcelona. Departament de Medicina) ; Molina, Israel (Hospital Universitari Vall d'Hebron)
Chronic chagasic cardiomyopathy (CCC) is the most important complication of patients with Chagas disease (CD). The role of persistent detection of DNA in peripheral blood and its association to CCC is unknown. [...]
2022 - 10.3389/fcvm.2021.787214
Frontiers in Cardiovascular Medicine, Vol. 8 (january 2022)  
3.
8 p, 1.7 MB Blastocystis sp. Carriage and Irritable Bowel Syndrome : Is the Association Already Established? / Salvador, Fernando (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Lobo, Beatriz (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Goterris, Lidia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Alonso Cotoner, Carmen (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Santos, Javier (Universitat Autònoma de Barcelona. Departament de Medicina) ; Sulleiro, Elena (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Bailo, Begoña (National Centre of Microbiology, Instituto de Salud Carlos III, 28220 Madrid, Spain; (B.B.); (D.C.); (I.F.)) ; Carmena, David (National Centre of Microbiology, Instituto de Salud Carlos III, 28220 Madrid, Spain; (B.B.); (D.C.); (I.F.)) ; Sánchez-Montalvá, Adrián (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Bosch-Nicolau, Pau (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Espinosa-Pereiro, Juan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Fuentes, Isabel (National Centre of Microbiology, Instituto de Salud Carlos III, 28220 Madrid, Spain; (B.B.); (D.C.); (I.F.)) ; Molina, Israel (Hospital Universitari Vall d'Hebron. Institut de Recerca)
The intestinal protist Blastocystis sp. is one of the most common intestinal parasites observed in humans, and has a worldwide distribution, being more prevalent in developing countries. Although this parasite has been described decades ago, the pathogenic potential it is still not understood completely. [...]
2021 - 10.3390/biology10040340
Biology, Vol. 10 (april 2021)  
4.
10 p, 658.6 KB Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study) : study protocol for a multicenter randomized Phase II non-inferiority clinical trial / Molina-Morant, D. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Fernández, M. L. (Ministerio de Salud y Desarrollo Social) ; Bosch-Nicolau, Pau (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Sulleiro, Elena (Hospital Universitari Vall d'Hebron) ; Bangher, M. (Instituto de Cardiología de Corrientes Juana Francisca Cabral (Argentina)) ; Salvador, F. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Sanchez-Montalva, A. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ribeiro, A. L. P. (Faculdade de Medicina da Universidade Federal de Minas Gerais) ; de Paula, A. M. B. (Universidade Estadual de Montes Claros) ; Eloi, S. (Faculdade de Medicina da Universidade José do Rosário Vellano) ; Correa-Oliveira, Rodrigo (René Rachou Institute) ; Villar, J. C. (Universidad Autónoma de Bucaramanga) ; Sosa-Estani, S. (Epidemiology and Public Health Research Center, CONICET) ; Molina Romero, Israel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Chagas disease (CD) continues to be a neglected infectious disease with one of the largest burdens globally. Despite the modest cure rates in adult chronic patients and its safety profile, benznidazole (BNZ) is still the drug of choice. [...]
2020 - 10.1186/s13063-020-4226-2
Trials, Vol. 21 (april 2020)  
5.
12 p, 182.8 KB Strongyloides stercoralis infection : A systematic review of endemic cases in Spain / Barroso, Maria (Universitat Autònoma de Barcelona) ; Salvador, Fernando (Hospital Universitari Vall d'Hebron) ; Sánchez-Montalvá, Adrián (Hospital Universitari Vall d'Hebron) ; Bosch-Nicolau, Pau (Hospital Universitari Vall d'Hebron) ; Molina Romero, Israel (Hospital Universitari Vall d'Hebron)
Strongyloides stercoralis infection, a neglected tropical disease, is widely distributed. Autochthonous cases have been described in Spain, probably infected long time ago. In recent years the number of diagnosed cases has increased due to the growing number of immigrants, travelers and refugees, but endemically acquired cases in Spain remains undetermined. [...]
2019 - 10.1371/journal.pntd.0007230
PLoS neglected tropical diseases, Vol. 13 (march 2019)  
6.
5 p, 322.3 KB Microscopic examination after concentration techniques for Blastocystis sp. detection in serial faecal samples : How many samples are needed? / Not, Anna (Universitat Autònoma de Barcelona) ; Salvador, Fernando (Hospital Universitari Vall d'Hebron) ; Goterris, Lidia (Hospital Universitari Vall d'Hebron) ; Sulleiro, Elena (Hospital Universitari Vall d'Hebron) ; López, Isabel (Hospital Universitari Vall d'Hebron) ; Balladares, Martha (Hospital Universitari Vall d'Hebron) ; García, Elena (Hospital Universitari Vall d'Hebron) ; Paz, Carmen (Hospital Universitari Vall d'Hebron) ; Sánchez-Montalvá, Adrián (Hospital Universitari Vall d'Hebron) ; Bosch-Nicolau, Pau (Hospital Universitari Vall d'Hebron) ; Sao-Avilés, Augusto (Hospital Universitari Vall d'Hebron) ; Molina Romero, Israel (Hospital Universitari Vall d'Hebron)
Blastocystis sp. is one of the most frequently observed intestinal parasites in humans. It is suggested that sensitivity of classical parasitological tests for the Blastocystis sp. diagnosis increases when increasing the number of investigated samples, although there is a lack of information. [...]
2020 - 10.1016/j.parepi.2020.e00137
Parasite Epidemiology and Control, Vol. 9 (january 2020)  
7.
3 p, 428.0 KB A case report of long treatment with Itraconazole in a patient with chronic Chagas disease / Bosch-Nicolau, Pau (Universitat Autònoma de Barcelona. Departament de Medicina) ; Salvador, Fernando (Hospital Universitari Vall d'Hebron) ; Sánchez-Montalvá, Adrián (Hospital Universitari Vall d'Hebron) ; Sulleiro, Elena (Hospital Universitari Vall d'Hebron) ; Burgos, Joaquín (Hospital Universitari Vall d'Hebron) ; Molina Romero, Israel (Hospital Universitari Vall d'Hebron)
Background: Current available treatments (benznidazole and nifurtimox) for Chagas disease (CD) show limited efficacy in chronic phase and frequent undesirable effects. Ergosterol synthesis inhibitors (ESI) had been considered as promising drugs for CD treatment and despite its recent poor results in several clinical trials, different strategies have been proposed to optimize its role in this infection. [...]
2019 - 10.1186/s12879-019-4608-9
BMC Infectious diseases, Vol. 19 (november 2019)  
8.
16 p, 1.3 MB Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression / Bosch-Nicolau, Pau (Hospital Universitari Vall d'Hebron) ; Ubals, Maria (Hospital Universitari Vall d'Hebron) ; Salvador, Fernando (Hospital Universitari Vall d'Hebron) ; Sánchez-Montalvá, Adrián (Hospital Universitari Vall d'Hebron) ; Aparicio, Gloria (Hospital Universitari Vall d'Hebron) ; Erra Duran, Alba (Hospital Universitari Vall d'Hebron) ; Martínez de Salazar, Pablo (Hospital Universitari Vall d'Hebron) ; Sulleiro, Elena (Hospital Universitari Vall d'Hebron) ; Molina Romero, Israel (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Background Tumor necrosis factor alpha (TNF-α) blockers are recognized as a risk factor for reactivation of granulomatous infections. Leishmaniasis has been associated with the use of these drugs, although few cases have been reported. [...]
2019 - 10.1371/journal.pntd.0007708
PLoS neglected tropical diseases, Vol. 13 Núm. 8 (2019) , p. e0007708  

Vegeu també: autors amb noms similars
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.